The Icahn School of Medicine at Mount Sinai is one of 16 academic medical research centers to participate in the Asian Cohort for Alzheimer’s Disease (ACAD) study, funded by a $40.5 million grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). The project represents the first major Alzheimer’s disease genetics cohort for Asian Americans and Asian Canadians, populations currently underrepresented in Alzheimer’s disease research.